Trial Details

TERMINATED
Basic Information
Clinical ID c1863
Identifier NCT04316806
Trial Title Effect of a Probiotic Formula on Reducing SIBO in IBS Patients
Trial URL Visit Original Page
Study Information
Study Results

NO

Conditions Irritable Bowel Syndrome|Small Intestinal Bacterial Overgrowth
Interventions DIETARY_SUPPLEMENT: Probiotic|DRUG: Rifaximin
Participant Information
Sponsor AB Biotics, SA
City Girona
Country/Region Spain
Enrollment Criteria
Sex Requirement ALL
Age Requirement ADULT, OLDER_ADULT
Study Design
Study Type INTERVENTIONAL
Phase NA
Time Information
Start Date 2020-11-20
Primary Completion Date 2022-09-01
Completion Date 2022-09-01